Experimental Intranasal DNA Vaccine Developed by Johns Hopkins Researchers Targets Drug-Tolerant Tuberculosis Persisters to Prevent Relapse
Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have...
Knowledge and News for the Global Fight Against Cancer.
Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have...
Cardiovascular diseases (CVDs) claim nearly 20 million lives each year, making them the leading cause...
Paris, France, and Tarrytown, New York – In a strategic move designed to extend their...
A groundbreaking study involving over 5,500 adults aged 50 and older has unearthed a concerning...
In the complex landscape of cellular biology, tumor suppressor genes have long been heralded as...
The medical community and pediatric cancer advocates are closely monitoring the case of Lily, a...
CureSearch for Children’s Cancer has officially announced that Dr. Robbie Majzner of the Dana-Farber Cancer...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
A groundbreaking new study suggests a transformative shift in breast cancer screening practices, advocating for...
Mesothelioma, a rare and exceptionally aggressive cancer, is predominantly linked to occupational or environmental exposure...